Search results
Taysha links gene therapy to motor gains in small Rett study
FierceBiotech· 5 days agoTaysha Gene Therapies has unfurled more data in the developmental disorder Rett syndrome, linking...
Meridian Small Cap Growth Fund Trimmed Neurogene (NGNE) on Share Price Appreciation
Insider Monkey via Yahoo Finance· 4 days agoMeridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” first...
What's Going On With Taysha Gene Therapies Stock Tuesday? - Taysha Gene Therapies (NASDAQ:TSHA)
Benzinga· 5 days agoInc TSHA released longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 ...
Achievement Center for Adults with Disabilities Opens in Paramus
New Jersey Business Magazine· 5 days agoNew Concepts for Living (NCFL), a provider of community residences, day programs, and therapeutic...
Leslie Mehta wins Democratic nomination, will take on Rob Wittman in 1st District
Daily Press· 5 days agoLeslie Mehta has won the Democratic Primary for U.S. House District 1 in Virginia and will run...
Leslie Mehta wins Democratic nomination in Virginia’s 1st Congressional District primary
WRIC 8 News Richmond· 5 days agoDemocrat Leslie C. Mehta will challenge Republican Rep. Rob Wittman in November after defeating Herb...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 6 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
What happened to old Paramus Barnes & Noble? Nonprofit starts new chapter at Rt. 17 site
The Bergen Record via Yahoo News· 5 days agoIndividuals in its day programs and group homes include those with autism, cerebral palsy, Down...
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day...
Benzinga· 5 days agoShares of Quantum Corporation QMCO fell sharply during Tuesday's session after the company reported...
Brokerages Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $48.60
ETF DAILY NEWS· 22 hours agoNeurogene Inc. (NASDAQ:NGNE – Get Free Report) has been assigned an average rating of “Buy” from the eight brokerages that are covering the company, Marketbeat Ratings reports. Seven analysts ...